SDSS yields 2000000.00% · JNJ yields 2.14%● Live data
📍 SDSS pulled ahead of the other in Year 1
Combined, SDSS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SDSS + JNJ for your $10,000?
Suspect Detection Systems Inc., through its subsidiary, Suspect Detection Systems Ltd., engages in the development and application of proprietary technologies for law enforcement and border control. The company offers Cogito line of products, which are based on proprietary software and use commercially available hardware to identify individuals that pose security threats, whether or not they are carrying a weapon on their person or in their belongings. Its products comprise Cogito4M-Mobile System; Cogito4M - Military Grade Rigid Manpack System; and Cogito 1003 Standalone Mass Screening Unit. The company also develops behavior based screening technologies for the checkpoint screening market. It offers technologies for use in counter terrorism efforts, immigration control, and drug enforcement, as well as human resource management, asset management, and transportation sectors. The company was formerly known as PCMT Corporation and changed its name to Suspect Detection Systems Inc. in January 2009. Suspect Detection Systems Inc. was incorporated in 2006 and is based in New York, New York.
Full SDSS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.